TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
40.06
+0.76 (1.93%)
At close: Jun 6, 2025, 4:00 PM
40.25
+0.19 (0.47%)
After-hours: Jun 6, 2025, 7:56 PM EDT

TG Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
132.14179.8992.93102.3298.89553.44
Upgrade
Short-Term Investments
144.1131.11124.5859.3715.8851.99
Upgrade
Cash & Short-Term Investments
276.24311217.51161.68314.76605.43
Upgrade
Cash Growth
31.68%42.98%34.53%-48.63%-48.01%331.11%
Upgrade
Accounts Receivable
190.12129.1951.09-1.39-
Upgrade
Receivables
190.12129.1951.09-1.39-
Upgrade
Inventory
157.76110.4639.82---
Upgrade
Other Current Assets
20.3915.729.526.614.816.31
Upgrade
Total Current Assets
644.51566.36317.94168.27330.97611.74
Upgrade
Property, Plant & Equipment
6.937.158.059.29.239.79
Upgrade
Long-Term Investments
1.910.81-12.435.53-
Upgrade
Goodwill
---0.80.80.8
Upgrade
Long-Term Deferred Charges
---1.631.842.05
Upgrade
Other Long-Term Assets
3.353.373.591.271.261.26
Upgrade
Total Assets
656.69577.69329.59193.57379.63625.64
Upgrade
Accounts Payable
93.8326.329.2742.0250.8937.01
Upgrade
Accrued Expenses
5.1415.1912.178.4310.178.46
Upgrade
Current Portion of Long-Term Debt
0.870.660.360.241.3423.12
Upgrade
Current Portion of Leases
1.121.161.451.581.441.67
Upgrade
Current Unearned Revenue
17.0811.410.15-0.20.2
Upgrade
Other Current Liabilities
42.1735.9710.320.931.3517.1
Upgrade
Total Current Liabilities
160.2190.6853.7253.265.3887.55
Upgrade
Long-Term Debt
244.73244.43100.1271.1466.797.72
Upgrade
Long-Term Leases
7.868.139.2310.349.8510.41
Upgrade
Long-Term Unearned Revenue
6.612.096.020.310.460.61
Upgrade
Total Liabilities
419.4355.33169.09134.99142.48106.29
Upgrade
Common Stock
0.160.160.150.150.140.14
Upgrade
Additional Paid-In Capital
1,7761,7601,7131,5861,5661,500
Upgrade
Retained Earnings
-1,524-1,529-1,553-1,527-1,329-980.6
Upgrade
Treasury Stock
-15.12-8.99-0.23-0.23-0.23-0.23
Upgrade
Shareholders' Equity
237.29222.36160.558.59237.15519.35
Upgrade
Total Liabilities & Equity
656.69577.69329.59193.57379.63625.64
Upgrade
Total Debt
254.58254.38111.1583.379.4142.91
Upgrade
Net Cash (Debt)
21.6656.62106.3678.38235.36562.51
Upgrade
Net Cash Growth
-77.85%-46.76%35.70%-66.70%-58.16%465.67%
Upgrade
Net Cash Per Share
0.130.350.720.581.784.88
Upgrade
Filing Date Shares Outstanding
145.82145.23144.78137.63130.79129.8
Upgrade
Total Common Shares Outstanding
145.23143.99141.79137.65131.22129.79
Upgrade
Working Capital
484.3475.68264.22115.07265.58524.19
Upgrade
Book Value Per Share
1.631.541.130.431.814.00
Upgrade
Tangible Book Value
237.29222.36160.557.79236.35518.55
Upgrade
Tangible Book Value Per Share
1.631.541.130.421.804.00
Upgrade
Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q